Silver Book Fact

Based on rates of admission in 1998, delaying admission of Alzheimer’s patients to nursing homes by 1 month could save as much as $1.12 billion a year.

Leon, Joel, Chang-Kuo Cheng, and Peter J. Neumann. Alzheimer s Disease Care: Costs and potential savings. Health Affairs. 1998; 17(6): 206-16. http://content.healthaffairs.org/cgi/content/abstract/17/6/206?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=leon&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

Reference

Title
Alzheimer s Disease Care: Costs and potential savings
Publication
Health Affairs
Publication Date
1998
Authors
Leon, Joel, Chang-Kuo Cheng, and Peter J. Neumann
Volume & Issue
Volume 17, Issue 6
Pages
206-16
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • A recent study showed that memantine, a medicine approved to treat moderate-to-severe Alzheimer’s, significantly slows cognitive decline and reduces the need for caregiving by 45.8 hours per month.  
  • According to the Pharmaceutical Research and Manufacturers of America, every $1 spent on Alzheimer’s research would save Medicare $10 by 2015 and $25 by 2025.  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 total cost of care (for all payers) for all people…  
  • The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.  
  • Out-of-Pocket Costs, 5-Year Delayed Onset